Analysts Set Chemed Corporation (NYSE:CHE) Price Target at $530.75

Shares of Chemed Corporation (NYSE:CHE) have been given an average rating of “Hold” by the six ratings firms that are covering the company, MarketBeat.com reports. Five research analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $530.75.

A number of analysts have issued reports on the company. Oppenheimer raised their target price on Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a report on Friday, July 31st. Royal Bank Of Canada upped their price target on Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a report on Thursday, July 30th. Wall Street Zen raised Chemed from a “hold” rating to a “strong-buy” rating in a research report on Saturday, August 1st. Weiss Ratings upgraded shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, July 17th. Finally, Bank of America reaffirmed a “neutral” rating on shares of Chemed in a research report on Wednesday, July 29th.

Chemed Stock Up 0.6%

CHE stock opened at $523.57 on Monday. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.91 and a quick ratio of 0.89. Chemed has a 52-week low of $365.20 and a 52-week high of $557.00. The company has a 50-day moving average of $509.45 and a two-hundred day moving average of $449.67. The stock has a market capitalization of $6.84 billion, a price-to-earnings ratio of 26.30, a price-to-earnings-growth ratio of 1.97 and a beta of 0.51.

Chemed (NYSE:CHE) last issued its quarterly earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.60 by $0.46. The company had revenue of $673.25 million for the quarter, compared to the consensus estimate of $665.04 million. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The firm’s revenue was up 8.8% compared to the same quarter last year. During the same period last year, the business posted $4.27 earnings per share. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. As a group, equities research analysts anticipate that Chemed will post 23.18 EPS for the current year.

Chemed Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 3rd. Stockholders of record on Monday, August 17th will be issued a dividend of $0.70 per share. This represents a $2.80 annualized dividend and a dividend yield of 0.5%. The ex-dividend date is Monday, August 17th. This is a positive change from Chemed’s previous quarterly dividend of $0.60. Chemed’s payout ratio is presently 14.06%.

Insider Activity at Chemed

In other news, EVP Spencer S. Lee sold 1,000 shares of the company’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $541.04, for a total transaction of $541,040.00. Following the completion of the transaction, the executive vice president owned 13,912 shares of the company’s stock, valued at approximately $7,526,948.48. This represents a 6.71% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Patrick P. Grace sold 190 shares of the stock in a transaction dated Friday, July 31st. The shares were sold at an average price of $532.00, for a total transaction of $101,080.00. Following the completion of the sale, the director owned 3,533 shares of the company’s stock, valued at approximately $1,879,556. The trade was a 5.10% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 6,537 shares of company stock worth $3,406,014. 3.33% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. Monetary Solutions Ltd acquired a new stake in Chemed during the fourth quarter worth $25,000. Los Angeles Capital Management LLC acquired a new position in shares of Chemed in the 4th quarter valued at $26,000. BOK Financial Private Wealth Inc. acquired a new position in shares of Chemed in the 4th quarter valued at $27,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in shares of Chemed during the 2nd quarter worth about $34,000. Finally, Versant Capital Management Inc lifted its holdings in shares of Chemed by 7,500.0% during the 2nd quarter. Versant Capital Management Inc now owns 76 shares of the company’s stock worth $35,000 after acquiring an additional 75 shares during the period. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.